Talal Dahhan to Treatment Outcome
This is a "connection" page, showing publications Talal Dahhan has written about Treatment Outcome.
Connection Strength
0.147
-
Abdulelah M, Ezenna C, Jenil-Franco A, Jamouss KT, Krishna MM, Joseph M, Chi KY, Dahhan T. Clinical outcomes and safety of sotatercept in pulmonary arterial hypertension: A systematic review and meta-analysis of randomized controlled trials. Vascul Pharmacol. 2025 Sep; 160:107520.
Score: 0.110
-
Parikh KS, Doerfler S, Shelburne N, Kennedy K, Whitson J, Dahhan T, Fortin T, Rajagopal S. Experience in Transitioning From Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension. J Cardiovasc Pharmacol. 2020 04; 75(4):299-304.
Score: 0.019
-
Parikh KS, Dahhan T, Nicholl L, Ruopp N, Pomann GM, Fortin T, Tapson VF, Rajagopal S. Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension. Sci Rep. 2019 03 11; 9(1):4061.
Score: 0.018